Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

被引:56
作者
Felton, TM
Kang, TB
Hjorth, S
Auerbach, SB
机构
[1] Rutgers State Univ, Nelson Biol Labs, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA
[2] AstraZeneca R&D, Integrat Pharmacol, Molndal, Sweden
关键词
serotonin; (5-hydroxytryptamine; 5-HT); selective serotonin reuptake inhibitor (SSRI); mixed serotonin/noradrenaline reuptake inhibitor (SNRI); microdialysis; noradrenaline (norepinephrine); depression;
D O I
10.1007/s00210-002-0688-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Some clinical reports suggest that tricyclic antidepressants which block both noradrenaline and serotonin (5-HT) reuptake (SNRIs) are more effective than selective 5-HT reuptake inhibitors (SSRIs) in treating severe depression. Moreover, one neurochemical study reported larger increases in extracellular 5-HT in rat frontal cortex in response to the tricyclic antidepressant imipramine compared to the SSRI fluoxetine. However, imipramine, which blocks both 5-HT and noradrenaline reuptake, also binds with relatively high affinity to receptors for noradrenaline, histamine and acetylcholine. Thus, to test the hypothesis that compounds that inhibit both 5-HT and noradrenaline reuptake produce larger increases in 5-HT efflux, we compared the effects of acute systemic administration of several SNRIs and SSRIs. Extracellular 5-HT was measured using microdialysis probes implanted in the diencephalon and frontal cortex of unanesthetized rats. We tested the SSRIs paroxetine (0.3-10 mg/kg), citalopram (10-20 mg/kg) and fluoxetine (10 mg/kg), the nonselective tricyclic antidepressant imipramine (20 mg/kg) and the more selective SNRIs duloxetine (3-30 mg/kg) and venlafaxine (30-50 mg/kg). During the lights-off period, paroxetine and duloxetine increased 5-HT in the diencephalon similar to300 and similar to200%, respectively. During the lights-on period, paroxetine and duloxetine each increased 5-HT similar to400% in the diencephalon. In the frontal cortex, both paroxetine and duloxetine increased 5-HT similar to200%. Citalopram and venlafaxine each increased 5-HT in the diencephalon similar to300%. Fluoxetine and imipramine increased 5-HT in the diencephalon by similar to125 and similar to80%, respectively. Thus, these results do not support the hypothesis that compared to SSRIs, compounds which inhibit both 5-HT and noradrenaline reuptake have a larger acute effect on extracellular 5-HT.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 44 条
[1]   Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability [J].
Anderson, IM .
JOURNAL OF AFFECTIVE DISORDERS, 2000, 58 (01) :19-36
[2]   DIFFERENTIAL INHIBITION OF SEROTONIN RELEASE BY 5-HT AND NA REUPTAKE BLOCKERS AFTER SYSTEMIC ADMINISTRATION [J].
AUERBACH, SB ;
LUNDBERG, JF ;
HJORTH, S .
NEUROPHARMACOLOGY, 1995, 34 (01) :89-96
[3]   SUPPRESSION OF FIRING ACTIVITY OF 5-HT NEURONS IN THE DORSAL RAPHE BY ALPHA-ADRENOCEPTOR ANTAGONISTS [J].
BARABAN, JM ;
AGHAJANIAN, GK .
NEUROPHARMACOLOGY, 1980, 19 (04) :355-363
[4]   Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine:: a comparative study with paroxetine and desipramine [J].
Béïque, JC ;
de Montigny, C ;
Blier, P ;
Debonnel, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (03) :526-532
[5]   Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters [J].
Béïque, JC ;
Lavoie, N ;
de Montigny, C ;
Debonnel, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 349 (01) :129-132
[6]  
Bel N, 1996, J PHARMACOL EXP THER, V278, P1064
[7]   CHRONIC TREATMENT WITH FLUVOXAMINE INCREASES EXTRACELLULAR SEROTONIN IN FRONTAL-CORTEX BUT NOT IN RAPHE NUCLEI [J].
BEL, N ;
ARTIGAS, F .
SYNAPSE, 1993, 15 (03) :243-245
[8]   Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex [J].
Bymaster, FP ;
Zhang, W ;
Carter, PA ;
Shaw, J ;
Chernet, E ;
Phebus, L ;
Wong, DT ;
Perry, KW .
PSYCHOPHARMACOLOGY, 2002, 160 (04) :353-361
[9]   Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex:: augmentation via 5-HT1A receptor antagonism [J].
Dawson, LA ;
Nguyen, HQ ;
Geiger, A .
NEUROPHARMACOLOGY, 1999, 38 (08) :1153-1163
[10]   Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial [J].
de Montigny, C ;
Silverstone, PH ;
Debonnel, G ;
Blier, P ;
Bakish, D .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) :401-406